Progress in Cardiovascular Diseases
Volume 45, Issue 2 , Pages 157-172 , September 2002

Chronic heart failure–related myopathy and exercise training: A developing therapy for heart failure symptoms

References 

  1. Cleland JGF, Khand A, Clark A. The heart failure epidemic: Exactly how big is it?. Eur Heart J. 2001;22:623–626
  2. Coats AJS. Is preventive medicine responsible for the increasing prevalence of heart failure?. Lancet. 1998;352(suppl I):SI39–SI41
  3. Braunwald E. Congestive heart failure. Eur Heart J. 2001;22:813–825
  4. Ho KKL, Anderson KM, Kannel WB, et al.  Survival after the onset of congestive heart failure in the Framingham heart study subjects. Circulation. 1993;88:107–115
  5. Stevenson LW, Steimle AE, Fonarow G, et al.  Improvement in exercise capacity of candidates awaiting heart transplantation. J Am Coll Cardiol. 1995;25:163–170
  6. Sullivan MJ, Hawthorne MH. Exercise intolerance in patients with chronic heart failure. Progr Cardiovasc Dis. 1995;1:1–22
  7. Wilson JR. Exercise intolerance in heart failure. Importance of skeletal muscle. Circulation. 1995;91:559–560
  8. Clark AL, Poole-Wilson PA, Coats AJS. Exercise limitation in chronic heart failure: Central role of the periphery. J Am Coll Cardiol. 1996;28:1092–1102
  9. Lipkin DP, Jones DA, Round JM, et al.  Abnormalities of skeletal muscle in patients with chronic heart failure. Int J Cardiol. 1988;18:187–195
  10. Minotti JR, Pillay P, Oka R, et al.  Skeletal muscle size: Relationship to muscle function in heart failure. J Appl Physiol. 1993;75:373–381
  11. Minotti JR, Pillay P, Chang L, et al.  Neurophysiological assessment of skeletal muscle fatigue in patients with congestive heart failure. Circulation. 1992;86:903–908
  12. Harrington DD, Anker S, Chua T, et al.  Skeletal muscle function and its relation to exercise tolerance in chronic heart failure. J Am Coll Cardiol. 1997;30:1758–1764
  13. Opasich C, Ambrosino N, Felicetti G, et al.  Heart failure-related myopathy. Clinical and pathophysiological insights. Eur Heart J. 1999;20:1191–1200
  14. Minotti JR, Christoph I, Oka R, et al.  Impaired skeletal muscle function in patients with congestive heart failure. Relationship to systemic exercise performance. J Clin Invest. 1991;88:2077–2082
  15. Anker SD, Swan JW, Volterrani M, et al.  The influence of muscle mass, strength, fatigability, and blood flow on exercise capacity in cachectic and non-cachectic patients with chronic heart failure. Eur Heart J. 1996;18:259–269
  16. Volterrani M, Clark AL, Ludman PF, et al.  Predictors of exercise capacity in chronic heart failure. Eur Heart J. 1994;15:801–809
  17. Mancini DM, Reicheck N, Chance B, et al.  Contribution of skeletal muscle atrophy to exercise intolerance and altered muscle metabolism in chronic heart failure. Circulation. 1992;85:1364–1373
  18. Lang CC, Chomsky DB, Rayos G, et al.  Skeletal muscle mass and exercise performance in stable ambulatory patients with heart failure. J Appl Physiol. 1997;82:257–261
  19. Cicoira M, Zanolla L, Franceschini L, et al.  Skeletal muscle mass independently predicts peak oxygen consumption and ventilatory response during exercise in noncachectic patients with chronic heart failure. J Am Coll Cardiol. 2001;37:2080–2085
  20. Shepard R, Bouhlel E, Vandewalle H, et al.  Muscle mass: A factor limiting physical work. J Appl Physiol. 1988;64:1472–1479
  21. Shafiq SA, Sande MA, Carruthers RR, et al.  Skeletal muscle in idiopathic cardiomyopathy. J Neurol Sci. 1972;15:303–320
  22. Sullivan MJ, Green HJ, Cobb FR. Skeletal muscle biochemistry and histology in ambulatory patients with long-term heart failure. Circulation. 1990;81:518–527
  23. Drexler H, Riede U, Munzel T, et al.  Alterations of skeletal muscle in chronic heart failure. Circulation. 1992;85:1751–1759
  24. Schaufelberger M, Eriksson BO, Grimby G, et al.  Skeletal muscle alterations in patients with chronic heart failure. Eur Heart J. 1997;18:971–980
  25. Vescovo G, Serafini F, Dalla Libera L, et al.  Skeletal muscle myosin heavy chains in heart failure: Correlation between magnitude of the isozyme shift, exercise capacity, and gas exchange measurements. Am Heart J. 1998;135:130–137
  26. Dunnigan A, Staley NA, Smith SA, et al.  Cardiac and skeletal muscle abnormalities in cardiomyopathy: Comparison of patients with ventricular tachycardia or congestive heart failure. J Am Coll Cardiol. 1987;10:608–618
  27. Lindsay DC, Lovergrove CA, Dunn MJ, et al.  Histological abnormalities of muscle from limb, thorax, and diaphragm in chronic heart failure. Eur Heart J. 1996;17:1239–1250
  28. Adams V, Jiang H, Jiangtao Yu, et al.  Apoptosis in skeletal myocytes of patients with chronic heart failure is associated with exercise intolerance. J Am Coll Cardiol. 1999;33:959–965
  29. Vescovo G, Volterrani M, Zennaro R, et al.  Apoptosis in the skeletal muscle of patients with heart failure: Investigation of clinical and biochemical changes. Heart. 2000;84:431–437
  30. Vescovo G, Ambrosio GB, Dalla Libera L. Apoptosis and changes in contractile protein pattern in the skeletal muscle in heart failure. Acta Physiol Scand. 2001;171:305–310
  31. Wilson JR, Fink L, Maris J, et al.  Evaluation of energy metabolism in skeletal muscle of patients with heart failure with gated phosphorus-31 nuclear magnetic resonance. Circulation. 1985;1:57–62
  32. Wiener DH, Fink LI, Maris J, et al.  Abnormal skeletal muscle bioenergetics during exercise in patients with heart failure: Role of reduced muscle blood flow. Circulation. 1986;6:1127–1136
  33. Massie BM, Conway M, Rajagopalan B, et al.  Skeletal muscle metabolism during exercise under ischemic conditions in congestive heart failure: Evidence for abnormalities unrelated to blood flow. Circulation. 1988;78:320–326
  34. Mancini DM, Coyle E, Coggan A, et al.  Contribution of intrinsic skeletal muscle changes to 31P NMR skeletal muscle metabolic abnormalities in patients with chronic heart failure. Circulation. 1989;80:1338–1346
  35. Yancy CW, Parsons D, Lane L, et al.  Capillary density, fiber type, and enzyme composition of skeletal muscle in congestive heart failure. J Am Coll Cardiol. 1989;13:38A; (abstr)
  36. Sullivan MJ, Howard JG, Cobb FR. Altered skeletal muscle metabolic response to exercise in chronic heart failure. Circulation. 1991;84:1597–1607
  37. Schaufelberger M, Eriksson BO, Held P, et al.  Skeletal muscle metabolism during exercise in patients with chronic heart failure. Heart. 1996;76:29–34
  38. Okita K, Yonezawa K, Nishijima H, et al.  Skeletal muscle metabolism limits exercise capacity in patients with chronic heart failure. Circulation. 1998;98:1886–1891
  39. Mettauer B, Zoll J, Sanchez H, et al.  Oxidative capacity of skeletal muscle in heart failure patients versus sedentary or active control subjects. J Am Coll Cardiol. 2001;38:947–954
  40. Nascimben L, Ingwall JS, Pauletto P, et al.  Creatine kinase system in failing and nonfailing human myocardium. Circulation. 1996;94:1894–1901
  41. Broqvist M, Dahlstrom U, Karlsson E, et al.  Muscle energy metabolism in severe chronic congestive heart failure: Effect of treatment with enalapril. Eur Heart J. 1992;13:1217–1224
  42. Opasich C, Aquilani R, Dossena M, et al.  Biochemical analysis of muscle biopsy in overnight fasting patients with severe heart failure. Eur Heart J. 1996;17:1686–1693
  43. Xu L, Poole DC, Musch TI. Effect of heart failure on muscle capillary geometry: Implications for O2 exchange. Med Sci Sports Exerc. 1998;30:1230–1237
  44. Duscha BD, Kraus WE, Keteyan SJ, et al.  Capillary density of skeletal muscle. A contributing mechanism for exercise intolerance in class II-III chronic heart failure independent of other peripheral alterations. J Am Coll Cardiol. 1999;33:1956–1963
  45. Longhurst J, Capone RJ, Zelis R. Evaluation of skeletal muscle basement membrane thickness in congestive heart failure. Chest. 1975;67:195–198
  46. Lindsay DC, Anand IS, Bennet JG, et al.  Ultrastructural analysis of skeletal muscle. Microvascular dimension and basement membrane thickness in chronic heart failure. Eur Heart J. 1994;15:1470–1476
  47. Nakamura M. Peripheral vascular remodeling in chronic heart failure: Clinical relevance and new conceptualization of its mechanisms. J Card Fail. 1999;5:127–138
  48. Kubo SH, Rector TS, Bank AJ, et al.  Endothelium-dependent vasodilation is attenuated in patients with heart failure. Circulation. 1991;84:1589–1596
  49. Yoshida H, Nakamura M, Akatsu T, et al.  Effects of nitric oxide inhibition on basal forearm blood flow in patients with non-ischemic heart failure. Heart Vessels. 1998;13:142–146
  50. Maguire SM, Nugent AG, McGurk C, et al.  Abnormal vascular responses in human chronic cardiac failure are both endothelium dependent and endothelium independent. Heart. 1998;80:141–145
  51. Nakamura M, Chiba M, Ueshima K, et al.  Impaired cholinergic peripheral vasodilation and its relationship to hyperemic calf blood flow response and exercise intolerance in patients with chronic heart failure. Int J Cardiol. 1995;48:139–146
  52. Nakamura M, Yoshida H, Arakawa N, et al.  Endothelium-dependent vasodilatation is not selectively impaired in patients with chronic heart failure secondary to valvular heart disease and congenital heart disease. Eur Heart J. 1996;17:1875–1881
  53. Lee P, Kubo SH, Rector TS, et al.  Time course of endothelial dysfunction in patients with heart failure. Circulation. 1997;96:I 671; (abstr)
  54. Indolfi C, Maione A, Volpe M, et al.  Forearm vascular responsiveness to alpha 1- and alpha 2-adrenoceptor stimulation in patients with congestive heart failure. Circulation. 1994;90:17–22
  55. Creager MA, Quigg RJ, Ren CJ, et al.  Limb vascular responsiveness to beta-adrenergic receptor stimulation in patients with congestive heart failure. Circulation. 1991;83:1873–1879
  56. Hirooka Y, Takeshita A, Imaizumi T, et al.  Attenuated forearm vasodilative response to intra-arterial atrial natriuretic peptide in patients with heart failure. Circulation. 1990;82:147–153
  57. Nakamura M, Arakawa N, Yoshida H, et al.  Vasodilatory effects of B-type natriuretic peptide are impaired in patients with chronic heart failure. Am Heart J. 1998;135:414–420
  58. Nakamura M, Yoshida H, Makita S, et al.  Potent and long-lasting vasodilatory effects of adrenomedullin in humans. Comparison between normal subjects and patients with chronic heart failure. Circulation. 1997;95:1214–1221
  59. Krum H, Katz SD. Effect of endothelin-1 on exercise-induced vasodilation in normal subjects and in patients with heart failure. Am J Cardiol. 1998;81:355–358
  60. Wilson JR, Martin JL, Schwartz D, et al.  Exercise intolerance in patients with chronic heart failure: Role of impaired nutritive flow to skeletal muscle. Circulation. 1984;69:1079–1087
  61. Sullivan MJ, Green HJ, Cobb FR. Relation between central and peripheral hemodynamics during exercise in patients with chronic heart failure: Muscle blood flow is reduced with maintenance of arterial perfusion pressure. Circulation. 1989;80:769–781
  62. Mancini DM, Wilson JR, Bollinger L, et al.  In vivo magnetic resonance spectroscopy measurement of deoxymyoglobin during exercise in patients with chronic heart failure: Demonstration of abnormal muscle metabolism despite adequate oxygenation. Circulation. 1994;90:500–508
  63. Chati Z, Zannad F, Jeandel C, et al.  Physical deconditioning may be a mechanism for the skeletal muscle energy phosphate metabolism abnormalities in chronic heart failure. Am Heart J. 1996;131:560–566
  64. Adamopoulos S, Kemp GJ, Thompson CH, et al.  The time course of haemodynamic, autonomic, and skeletal muscle metabolic abnormalities following first extensive myocardial infarction in man. J Mol Cell Cardiol. 1999;31:1913–1926
  65. Page E, Cohen-Solal A, Jondeau G, et al.  Comparison of treadmill and bicycle exercise in patients with chronic heart failure. Chest. 1994;106:1002–1006
  66. Lipkin DP, Canepa-Anson R, Stephens MR, et al.  Factors determining symptoms in heart failure: Comparison of fast and slow exercise tests. Br Heart J. 1986;55:439–445
  67. Gibbs JRS, Keegan J, Wright C, et al.  Pulmonary artery pressure changes during exercise and daily activities in chronic heart failure. J Am Coll Cardiol. 1990;15:52–61
  68. Clark AL, Sparrow JL, Coats AJS. Muscle fatigue and dyspnoea in chronic heart failure: Two sides of the same coin?. Eur Heart J. 1995;16:49–52
  69. Coats AJS, Clark AL, Piepoli M, et al.  Symptoms and quality of life in heart failure: The muscle hypothesis. Br Heart J. 1994;72:S36–S39
  70. Iwamoto GA, Waldrop TG, Kaufman MP, et al.  Pressor reflex evoked by muscular contraction: Contribution by neuraxis level. J Appl Physiol. 1985;59:459–467
  71. Pérez-Gonzales JF. Factors determining the blood pressure responses to isometric exercise. Circ Res. 1981;48:76–86
  72. Piepoli M, Clark AL, Poole-Wilson PA, et al.  Muscle metaboloreceptor in the hemodynamic, autonomic and ventilatory responses to exercise in men. Am J Physiol. 1995;38:H1428–H1436
  73. Flora JS. Clinical aspects of sympathetic activation and parasympathetic withdrawal in heart failure. J Am Coll Cardiol. 1993;4(suppl A):72A–84A
  74. Piepoli M, Ponikowski P, Clark AL, et al.  A neural link to explain the “muscle hypothesis” of exercise intolerance in chronic heart failure. Am Heart J. 1999;137:1050–1056
  75. Ponikowski P, Chua TP, Francis DP, et al.  Muscle ergoreceptor overactivity reflects deterioration in clinical status and cardiorespiratory reflex control in chronic heart failure. Circulation. 2001;104:2324–2330
  76. Ponikowski P, Anker S, Chua TP, et al.  Oscillatory breathing pattern during wakefulness in patients with chronic heart failure: Clinical implications and role of augmented peripheral chemosensitivity. Circulation. 1999;100:2418–2424
  77. Hawley JA. Adaptations of skeletal muscle to prolonged, intense endurance training. Clin Exp Pharmacol Physiol. 2002;29:218–222
  78. Cameron-Smith D. Exercise and skeletal muscle gene expression. Clin Exp Pharmacol Physiol. 2002;29:209–213
  79. Mitchell JH, Victor RG. Neural control of the cardiovascular system: Insights from muscle sympathetic nerve recordings in human. Med Sci Sports Exerc. 1996;28:S60–S69
  80. Coats AJS. Exercise training for heart failure. Coming of age. Circulation. 1999;99:1138–1140
  81. Piepoli MF, Scott AC, Capucci A, et al.  Skeletal muscle training in chronic heart failure. Acta Physiol Scand. 2001;171:295–303
  82. Magnusson G, Gordon A, Kaijser L, et al.  High intensity knee extensor training in patients with chronic heart failure. Eur Heart J. 1996;17:1048–1055
  83. Gordon A, Tyni-Lenné R, Persson H, et al.  Markedly improved skeletal muscle function with local muscle training in patients with chronic heart failure. Clin Cardiol. 1996;19:568–574
  84. Pu CT, Johnson MT, Forman DE, et al.  Randomized trial of progressive resistance training to counteract the myopathy of chronic heart failure. J Appl Physiol. 2001;90:2341–2350
  85. Delgardelle C, Feiereisen P, Krecke R, et al.  Objective effect of a 6 months' endurance and strength training program in outpatients with congestive heart failure. Med Sci Sport Exerc. 1999;31:1102–1107
  86. Minotti JR, Johnson EC, Hudson TL, et al.  Skeletal muscle response to exercise training in congestive heart failure. J Clin Invest. 1990;86:751–758
  87. Stratton JR, Dunn JF, Adamopoulos S, et al.  Training partially reverses skeletal muscle metabolic abnormalities during exercise in heart failure. J Appl Physiol. 1994;76:1575–1582
  88. Koch M, Donard H, Broustet JP. The benefit of grade physical exercise training in chronic heart failure. Chest. 1992;101:231S–235S
  89. Maiorana A, O'Driscoll G, Cheethaam C, et al.  Combined aerobic and resistance exercise training improves functional capacity and strength in CHF. J Appl Physiol. 2000;88:1565–1570
  90. Adamopoulos S, Coats AJS, Brunotte F, et al.  Physical training improves skeletal muscle metabolism in patients with chronic heart failure. J Am Coll Cardiol. 1993;21:1101–1106
  91. Belardinelli R, Georgiou D, Scocco V, et al.  Low intensity exercise training in patients with chronic heart failure. J Am Coll Cardiol. 1995;26:975–982
  92. Hambrecht R, Niebauer J, Fiehn E, et al.  Physical training in patients with stable chronic heart failure: Effects on cardiorespiratory fitness and ultrastructural abnormalities of leg muscles. J Am Coll Cardiol. 1995;25:1239–1249
  93. Hambrecht R, Fiehn E, Jiangtao Y, et al.  Effects of endurance training on mitochondrial ultrastructure and fiber type distribution in skeletal muscle of patients with stable chronic heart failure. J Am Coll Cardiol. 1997;29:1067–1073
  94. Hamilton MT, Booth FW. Skeletal muscle adaptation to exercise: A century of progress. J Appl Physiol. 2000;88:327–331
  95. Goldispink G. Selective gene expression during adaptation of muscle in response to different physiological demands. Comp Biochem Physiol J. 1998;120:5–15
  96. Changon YC, Rice T, Perusse L, et al.  Genomic scan for genes affecting body composition before and after training in Caucasians from HERITAGE. J Appl Physiol. 2001;90:1777–1787
  97. Williams A, Rayson M, Yubb M, et al.  The ACE gene and performance. Nature. 2000;403:614
  98. Folland S, Leach B, Liule T, et al.  Angiotensin-converting enzyme genotype affects the response of human skeletal muscle to functional overload. Exp Physiol. 2000;85:575–579
  99. Rankipen T, Perusse L, Gagnon J, et al.  Angiotensin-converting enzyme ID polymorphism and fitness phenotype in the HERITAGE family study. J Appl Physiol. 2000;88:1029–1035
  100. Sullivan MJ, Higginbotham MB, Cobb FR. Exercise training in patients with severe left ventricular dysfunction. Hemodynamic and metabolic effects. Circulation. 1988;78:506–515
  101. Sullivan MJ, Higginbotham MB, Cobb FR. Exercise training in patients with chronic heart failure delays ventilatory anaerobic threshold and improves submaximal exercise performance. Circulation. 1989;79:324–329
  102. Holloszy JO. Adaptation of muscular tissue to training. Prog Cardiovasc Dis. 1976;18:445–448
  103. Hambrecht R, Gielen S, Linke A, et al.  Effects of exercise training on left ventricular function and peripheral resistance in patients with chronic heart failure. JAMA. 2000;283:3095–3101
  104. Hornig B, Maier V, Drexler H. Physical training improves endothelial function in patients with chronic heart failure. Circulation. 1996;93:210–214
  105. Hambrecht R, Fiehn E, Weigl C, et al.  Regular physical training corrects endothelial dysfunction and improves exercise capacity in patients with chronic heart failure. Circulation. 1998;98:2709–2715
  106. Varin R, Mulder P, Richard V, et al.  Exercise improves flow-mediated vasodilation of skeletal muscle arteries in rats with chronic heart failure: Role of nitric oxide, prostanoids and oxidant stress. Circulation. 1999;99:2951–2957
  107. Resnick N, Gimbrone MA. Hemodynamic forces are complex regulators of endothelial gene expression. FASEB J. 1995;9:874–882
  108. Ennezat PV, Malendowicz SL, Testa M, et al.  Physical training in patients with chronic heart failure enhance the expression of genes encoding antioxidative enzymes. J Am Coll Cardiol. 2001;38:194–198
  109. Working Group on Cardiac Rehabilitation and Exercise Physiology and Working Group on Heart Failure of the European Society of Cardiology . Recommendations for exercise training in chronic heart failure patients. Eur Heart J. 2001;22:125–135
  110. Coats AJS, Adamopoulos S, Radaelli A, et al.  Controlled trial of physical training in chronic heart failure. Circulation. 1992;85:2119–2131
  111. Kilavouri K, Toivonen L, Naveri H, et al.  Reversal of autonomic derangements by physical training in chronic heart failure assessed by heart rate variability. Eur Heart J. 1995;16:490–495
  112. Giannuzzi P, Temporelli PL, Corrà U, et al.  Attenuation of unfavorable remodeling by exercise training in postinfarction patients with left ventricular dysfunction (ELVD) trial. Circulation. 1997;96:1790–1797
  113. Dubach P, Myers J, Dziekan G, et al.  Effect of exercise training on myocardial remodeling in patients with reduced left ventricular function after myocardial infarction. Circulation. 1997;96:2060–2067
  114. Giannuzzi P, Temporelli PL, Corrà U, et al.  Long-term exercise training in patients with chronic heart failure: Results of the ELVD-CHF trial. Circulation. 1997;96:I-771
  115. Hirsh AT, Dzau VS, Creager MA. Baroreceptor function in chronic heart failure: Effect of neurohumoral activation and regional vascular resistance. Circulation. 1987;75(suppl 4):36–48
  116. Ferguson DW, Berg WG, Roach PJ, et al.  Effects of heart failure on baroreflex control of sympathetic neural activity. Am J Cardiol. 1992;57:249–253
  117. European Heart Failure Training Group . Experience from controlled trials of physical training in chronic heart failure. Protocol and patient factors in the effectiveness in the improvement in exercise tolerance. Eur Heart J. 1998;19:466–475
  118. Piepoli M, Clark AL, Volterrani M, et al.  Contribution of muscle afferents to the hemodynamic, autonomic, and ventilatory responses to exercise in patients with chronic heart failure. Effects of physical training. Circulation. 1996;93:940–952
  119. Kilavouri K, Sovijarvi A, Naveri H, et al.  Effect of physical training on exercise capacity and gas exchange in patients with chronic heart failure. Chest. 1999;110:985–991
  120. Bouth FW, Watson PS. Control of adaptations in protein level in response to exercise. Fed Proc. 1985;44:2293–2300
  121. Atha J. Strengthening muscle. Exerc Sport Sci Rev. 1981;9:1–73
  122. Pollock ML, Evans WJ. Resistance training for health and disease. Med Sci Sport Exerc. 1999;31:10–11
  123. Pollock ML, Franklin BA, Balady GJ, et al.  Resistance training in individuals with and without cardiovascular disease. Circulation. 2000;101:828–833
  124. Meyer K, Hajric R, Westbrook S, et al.  Hemodynamic response during leg press exercise in patients with chronic congestive heart failure. Am J Cardiol. 1999;83:1537–1543
  125. Yan Z. Skeletal muscle adaptation and cell cycle regulation. Exerc Sport Sci Rev. 2000;28:24–26

 Address reprint requests to Ugo Corrá, MD, Divisione di Cardiologia, Fondazione “S. Maugeri,” Via per Revislate, 13, 28010 Veruno (NO), Italy.

PII: S0033-0620(02)70005-4

doi: 10.1053/pcad.2002.127490

Progress in Cardiovascular Diseases
Volume 45, Issue 2 , Pages 157-172 , September 2002